{ "labelLang" : "hun", "responseDate" : "2024-03-28 20:41", "content" : { "otype" : "BookChapter", "mtid" : 31238893, "status" : "APPROVED", "error" : "VALIDATION_ERROR", "published" : true, "comment" : "Department of Medicine, Division of Endocrinology and Metabolism, Edward Hines Jr. VA Hospital, Hines, IL, United States \n Department of Medicine, Division of Endocrinology and Metabolism, Loyola University Medical Center, Maywood, IL, United States \n Department of Medicine, Loyola University Medical Center, Maywood, IL, United States \n Export Date: 6 May 2020", "unhandledTickets" : 0, "deleted" : false, "lastRefresh" : "2024-02-12T11:28:11.149+0000", "lastModified" : "2023-08-01T10:37:10.485+0000", "created" : "2020-03-12T08:11:29.598+0000", "creator" : { "otype" : "Admin", "mtid" : 10071338, "link" : "/api/admin/10071338", "label" : "Molnár-Taga Márta (SE_AOK_1Bel_Onkol_Admin5_MTM, admin)", "familyName" : "Molnár-Taga", "givenName" : "Márta", "published" : true, "snippet" : true }, "duplumRole" : "SUSPECT", "lastDuplumOK" : "2024-02-12T11:01:45.860+0000", "lastDuplumSearch" : "2024-02-13T13:48:46.470+0000", "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Könyvrészlet", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000398, "link" : "/api/subtype/10000398", "label" : "Könyvfejezet (Könyvrészlet)", "name" : "Könyvfejezet", "nameEng" : "Chapter", "docType" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Könyvrészlet", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "listPosition" : 220, "published" : true, "oldId" : 10000398, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Meah, F.", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 91118715, "link" : "/api/authorship/91118715", "label" : "Meah, F.", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "corresponding" : false, "familyName" : "Meah", "givenName" : "F.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 91118716, "link" : "/api/authorship/91118716", "label" : "Charnogursky, G.", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Charnogursky", "givenName" : "G.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 91118717, "link" : "/api/authorship/91118717", "label" : "Patel, R.", "listPosition" : 3, "share" : 0.0, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Patel", "givenName" : "R.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 91118718, "link" : "/api/authorship/91118718", "label" : "Reddy, N.", "listPosition" : 4, "share" : 0.0, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Reddy", "givenName" : "N.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 91118719, "link" : "/api/authorship/91118719", "label" : "Agrawal, L.", "listPosition" : 5, "share" : 0.0, "first" : false, "last" : true, "corresponding" : false, "familyName" : "Agrawal", "givenName" : "L.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true } ], "title" : "Non-PTH-mediated hypercalcemia", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 16750833, "link" : "/api/publicationidentifier/16750833", "label" : "DOI: 10.1007/978-3-030-03694-2", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1007/978-3-030-03694-2", "realUrl" : "https://doi.org/10.1007/978-3-030-03694-2", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 16750832, "link" : "/api/publicationidentifier/16750832", "label" : "Scopus: 85067053719", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "85067053719", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85067053719", "published" : false, "snippet" : true } ], "firstPage" : "27", "lastPage" : "42", "firstPageOrInternalIdForSort" : "27", "pageLength" : 16, "publishedYear" : 2019, "abstractText" : "Hypercalcemia is a heterogeneous group of disorders with nonspecific signs and symptoms related to the level of serum calcium, the rate of rise of calcium, and the underlying condition causing hypercalcemia. It can be due to increased influx of calcium into the circulation from the intestine, kidneys, or bones and the failure of renal excretion to compensate for it. Causes of hypercalcemia can be categorized into parathyroid-dependent (PTH-mediated) and parathyroid-independent (non-PTH- mediated) disorders as outlined in Fig. 3.1. Parathyroid-dependent causes include primary and tertiary hyperparathyroidism (HPT), familial hypocalciuric hypercalcemia, and lithium-induced hypercalcemia. Primary hyperparathyroidism and hypercalcemia of malignancy account for ~90% of hypercalcemia. The finding of high serum calcium with suppressed or low-normal PTH values should suggest the less common PTH-independent hypercalcemias. Parathyroid-independent hypercalcemia encompasses hypercalcemia of malignancy, granulomatous disorders, endocrinopathies, medications, and a few other disorders. In this chapter, we will focus on parathyroid-independent hypercalcemia. © Springer Nature Switzerland AG 2019.", "keywords" : [ { "otype" : "Keyword", "mtid" : 19389, "link" : "/api/keyword/19389", "label" : "HYPERCALCEMIA", "published" : true, "oldId" : 19389, "snippet" : true }, { "otype" : "Keyword", "mtid" : 1009495, "link" : "/api/keyword/1009495", "label" : "vitamin D", "published" : true, "oldId" : 1009495, "snippet" : true }, { "otype" : "Keyword", "mtid" : 1994488, "link" : "/api/keyword/1994488", "label" : "1-25 dihydroxy vitamin D", "published" : true, "snippet" : true }, { "otype" : "Keyword", "mtid" : 1994489, "link" : "/api/keyword/1994489", "label" : "Parathyroid hormone-related peptide", "published" : true, "snippet" : true } ], "digital" : null, "printed" : null, "sourceYear" : 2020, "foreignEdition" : null, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : false, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2024-02-12", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 1, "citedCount" : 1, "referenceList" : "Stewart, A.F., Clinical practice. Hypercalcemia associated with cancer (2005) N Engl J Med, 352 (4), pp. 373-379 ;\n Wysolmerski, J.J., Parathyroid hormone-related protein: An update (2012) J Clin Endocrinol Metab, 97 (9), pp. 2947-2956 ;\n Goldner, W., Cancer-related hypercalcemia (2016) J Oncol Pract, 12 (5), pp. 426-432 ;\n Mirrakhimov, A.E., Hypercalcemia of malignancy: An update on pathogenesis and management (2015) N am J Med Sci, 7 (11), pp. 483-493 ;\n Strewler, G.J., The physiology of parathyroid hormone-related protein (2000) N Engl J Med, 342 (3), pp. 177-185 ;\n Roodman, G.D., Pathogenesis of myeloma bone disease (2010) J Cell Biochem, 109 (2), pp. 283-291 ;\n Barbaryan, A., Bailuc, S., Poddutoori, P., Richardson, A., Mirrakhimov, A.E., Gastrointestinal stromal tumor induced hypercalcemia (2017) Case Rep Oncol Med, 17, p. 2017 ;\n Edelson, G.W., Talpos, G.B., Bone, H.G., 3Rd, Hypercalcemia associated with Wegener’s granulomatosis and hyperparathyroidism: Etiology and management (1993) Am J Nephrol, 13 (4), pp. 275-277 ;\n Tuohy, K.A., Steinman, T.I., Hypercalcemia due to excess 1,25-dihydroxyvitamin D in Crohn’s disease (2005) Am J Kidney Dis, 45 (1), pp. e3-e6 ;\n Shumer, D.E., Thaker, V., Taylor, G.A., Wassner, A.J., Severe hypercalcaemia due to subcutaneous fat necrosis: Presentation, management and complications (2014) Arch Dis Child Fetal Neonatal Ed, 99 (5), pp. 419-421 ;\n Woywodt, A., Schneider, W., Goebel, U., Luft, F.C., Hypercalcemia due to talc granulomatosis (2000) Chest, 117 (4), pp. 1195-1196 ;\n Mason, R.S., Frankel, T., Chan, Y.L., Lissner, D., Posen, S., Vitamin, D., Conversion by sarcoid lymph node homogenate (1984) Ann Intern Med, 100 (1), pp. 59-61 ;\n Adams, J.S., Gacad, M.A., Singer, F.R., Sharma, O.P., Production of 1,25-dihydroxyvitamin D3 by pulmonary alveolar macrophages from patients with sarcoidosis (1986) Ann N Y Acad Sci, 465, pp. 587-594 ;\n Lind, L., Ljunghall, S., Hypercalcemia in pulmonary tuberculosis (1990) Ups J Med Sci, 95 (2), pp. 157-160 ;\n Tebben, P.J., Singh, R.J., Kumar, R., Vitamin D-mediated hypercalcemia: Mechanisms, diagnosis, and treatment (2016) Endocr Rev, 37 (5), pp. 521-547 ;\n Wang, Z., Lin, Y.S., Dickmann, L.J., Poulton, E.J., Eaton, D.L., Lampe, J.W., Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: Implications for drug-induced osteomalacia (2013) J am Soc Bone Miner Res, 28 (5), pp. 1101-1116 ;\n Baxter, J.D., Bondy, P.K., Hypercalcemia of thyrotoxicosis (1966) Ann Intern Med, 65 (3), pp. 429-442 ;\n Mosekilde, L., Christensen, M.S., Decreased parathyroid function in hyperthyroidism: Interrelationships between serum parathyroid hormone, calcium-phosphorus metabolism and thyroid function (1977) Acta Endocrinol, 84 (3), pp. 566-575 ;\n Bouillon, R., Muls, E., De Moor, P., Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3 (1980) J Clin Endocrinol Metab, 51 (4), pp. 793-797 ;\n Iqbal, A.A., Burgess, E.H., Gallina, D.L., Nanes, M.S., Cook, C.B., Hypercalcemia in hyperthyroidism: Patterns of serum calcium, parathyroid hormone, and 1,25-dihydroxyvitamin D3 levels during management of thyrotoxicosis (2003) Endocr Pract, 9 (6), pp. 517-521 ;\n Lakatos, P., Foldes, J., Horvath, C., Kiss, L., Tatrai, A., Takacs, I., Serum interleukin-6 and bone metabolism in patients with thyroid function disorders (1997) J Clin Endocrinol Metab, 82 (1), pp. 78-81 ;\n Kurihara, N., Bertolini, D., Suda, T., Akiyama, Y., Roodman, G.D., IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol (Baltimore (1990) MD: 1950), 144 (11), pp. 4226-4230 ;\n Cardoso, L.F., Maciel, L.M., Paula, F.J., The multiple effects of thyroid disorders on bone and mineral metabolism (2014) Arq Bras Endocrinol Metabol, 58 (5), pp. 452-463 ;\n Kimura, S., Nishimura, Y., Yamaguchi, K., Nagasaki, K., Shimada, K., Uchida, H., A case of pheochromocytoma producing parathyroid hormone-related protein and presenting with hypercalcemia (1990) J Clin Endocrinol Metab, 70 (6), pp. 1559-1563 ;\n Mune, T., Katakami, H., Kato, Y., Yasuda, K., Matsukura, S., Miura, K., Production and secretion of parathyroid hormone-related protein in pheochromocytoma: Participation of an alpha-adrenergic mechanism (1993) J Clin Endocrinol Metab, 76 (3), pp. 757-762 ;\n Muls, E., Bouillon, R., Boelaert, J., Lamberigts, G., Van Imschoot, S., Daneels, R., Etiology of hypercalcemia in a patient with Addison’s disease (1982) Calcif Tissue Int, 34 (6), pp. 523-526 ;\n Montoli, A., Colussi, G., Minetti, L., Hypercalcaemia in Addison’s disease: Calciotropic hormone profile and bone histology (1992) J Intern Med, 232 (6), pp. 535-540 ;\n Carroll, R., Matfin, G., Endocrine and metabolic emergencies: Hypercalcaemia (2010) Ther Adv Endocrinol Metabol, 1 (5), pp. 225-234 ;\n Manroa, P., Kannan, S., Hatipoglu, B., Licata, A., Hypercalcemia and acromegaly – clarifying the connections. A case report and review of the literature (2014) Endocr Pract, 20 (5), pp. e86-e90 ;\n Shah, R., Licata, A., Oyesiku, N.M., Ioachimescu, A.G., Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: Case reports and review of the literature (2012) Pituitary, 15 (1), pp. S17-S22 ;\n Eller-Vainicher, C., Ossola, M.W., Beck-Peccoz, P., Chiodini, I., PTHrP-associated hypercalcemia of pregnancy resolved after delivery: A case report (2012) Eur J Endocrinol/Eur Fed Endocr Soc, 166 (4), pp. 753-756 ;\n Cope, C., Base changes in the alkalosis produced by the treatment of gastric ulcer with alkalies (1936) Clin Sci, 2, pp. 287-300 ;\n Burnett, C.H., Commons, R.R., Albright, F., Howard, J.E., Hypercalcemia without hypercalciuria or hypophosphatemia, calcinosis and renal insufficiency: A syndrome following prolonged intake of milk and alkali (1949) N Engl J Med, 240 (20), pp. 787-794 ;\n Medarov, B.I., Milk-Alkali syndrome (2009) Mayo Clin Proc, 84 (3), pp. 261-267 ;\n Picolos, M.K., Lavis, V.R., Orlander, P.R., Milk–alkali syndrome is a major cause of hypercalcaemia among non-end-stage renal disease (Non-ESRD) inpatients (2005) Clin Endocrinol, 63 (5), pp. 566-576 ;\n Pettifor, J.M., Bikle, D.D., Cavaleros, M., Zachen, D., Kamdar, M.C., Ross, F.P., SErum levels of free 1,25-dihydroxyvitamin d in vitamin d toxicity (1995) Ann Intern Med, 122 (7), pp. 511-513 ;\n Haussler, M.R., Cordy, P.E., Metabolites and analogues of vitamin D: Which for what? (1982) JAMA, 247 (6), pp. 841-844 ;\n Hoeck, H.C., Laurberg, G., Laurberg, P., Hypercalcaemic crisis after excessive topical use of a vitamin D derivative (1994) J Intern Med, 235 (3), pp. 281-282 ;\n Bell, D., Crooke, M., Hay, N., Glendenning, P., Prolonged vitamin D intoxication: Presentation, pathogenesis and progress (2013) Intern Med J, 43 (10), pp. 1148-1150 ;\n Bhalla, K., Ennis, D.M., Ennis, E.D., Hypercalcemia caused by iatrogenic hypervitaminosis A (2005) J am Diet Assoc, 105 (1), pp. 119-121 ;\n Lippe, B., Hensen, L., Mendoza, G., Finerman, M., Welch, M., Chronic vitamin a intoxication: A multisystem disease that could reach epidemic proportions (1981) Am J Dis Child, 135 (7), pp. 634-636 ;\n Nijenhuis, T., Vallon, V., Van Der Kemp, A.W., Loffing, J., Hoenderop, J.G., Bindels, R.J., Enhanced passive Ca 2+ reabsorption and reduced Mg 2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia (2005) J Clin Invest, 115 (6), pp. 1651-1658 ;\n Haden, S.T., Stoll, A.L., McCormick, S., Scott, J., Fuleihan, G.-H., Alterations in parathyroid dynamics in lithium-treated subjects (1997) J Clin Endocrinol Metabol, 82 (9), pp. 2844-2848 ;\n Sloand, J.A., Shelly, M.A., Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride (2006) Am J Kidney Dis, 48 (5), pp. 832-837 ;\n Antoniucci, D.M., Sellmeyer, D.E., Bilezikian, J.P., Palermo, L., Ensrud, K.E., Greenspan, S.L., Elevations in serum and urinary calcium with parathyroid hormone (1–84) with and without alendronate for osteoporosis (2007) J Clin Endocrinol Metab, 92 (3), pp. 942-947 ;\n Mc, P.M., Prince, S.P., Atamer, E.P., Maxwell, D.B., Ross-Clunis, H., Estep, H.L., Theophylline-induced hypercalcemia (1986) Ann Intern Med, 105 (1), pp. 52-54 ;\n Legha, S.S., Powell, K., Buzdar, A.U., Blumenschein, G.R., Tamoxifen-induced hypercalcemia in breast cancer (1981) Cancer, 47 (12), pp. 2803-2806 ;\n Ipekci, S.H., Baldane, S., Ozturk, E., Araz, M., Korkmaz, H., Colkesen, F., Letrozole induced hypercalcemia in a patient with breast cancer (2014) Case Rep Oncol Med, 85, p. 2014 ;\n Visser, W., Van De Vyver, F., Aluminium-induced osteomalacia in severe chronic renal failure (SCRF) (1984) Clin Nephrol, 24, pp. S30-S36 ;\n Hutchison, A.J., Oral phosphate binders (2009) Kidney Int, 75 (9), pp. 906-914 ;\n Shike, M., Sturtridge, W.C., Tam, C.S., Harrison, J.E., Jones, G., Murray, T.M., A possible role of vitamin D in the genesis of parenteral-nutrition-induced metabolic bone disease (1981) Ann Intern Med, 95 (5), pp. 560-568 ;\n Hurley, D.L., McMahon, M.M., Long-term parenteral nutrition and metabolic bone disease (1990) Endocrinol Metab Clin N Am, 19 (1), pp. 113-131 ;\n Massagli, T.L., Cardenas, D.D., Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury (1999) Arch Phys Med Rehabil, 80 (9), pp. 998-1000 ;\n De Beus, E., Boer, W.H., Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failure (2012) Clin Kidney J, 5 (6), pp. 566-571 ;\n Jacobs, T.P., Bilezikian, J.P., Rare causes of hypercalcemia (2005) J Clin Endocrinol Metabol, 90 (11), pp. 6316-6322 ;\n Schipani, E., Langman, C.B., Parfitt, A.M., Jensen, G.S., Kikuchi, S., Kooh, S.W., Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen’s metaphyseal chondrodysplasia (1996) N Engl J Med, 335 (10), pp. 708-714 ;\n Garabedian, M., Jacqz, E., Guillozo, H., Grimberg, R., Guillot, M., Gagnadoux, M.F., Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies (1985) N Engl J Med, 312 (15), pp. 948-952 ;\n Culler, F.L., Jones, K.L., Deftos, L.J., Impaired calcitonin secretion in patients with Williams syndrome (1985) J Pediatr, 107 (5), pp. 720-723 ;\n Barcia, J.P., Strife, C.F., Langman, C.B., Infantile hypophosphatasia: Treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization (1997) J Pediatr, 130 (5), pp. 825-828 ;\n Meric, F., Yap, P., Bia, M.J., Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy (1990) Am J Kidney Dis, 16 (5), pp. 459-464 ;\n Akmal, M., Bishop, J.E., Telfer, N., Norman, A.W., Massry, S.G., Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure (1986) J Clin Endocrinol Metab, 63 (1), pp. 137-142 ;\n Gerhardt, A., Greenberg, A., Reilly, J.J., Jr., Van Thiel, D.H., Hypercalcemia. A complication of advanced chronic liver disease (1987) Arch Intern Med, 147 (2), pp. 274-277 ;\n Kuchay, M.S., Mishra, S.K., Farooqui, K.J., Bansal, B., Wasir, J.S., Mithal, A., Hypercalcemia of advanced chronic liver disease: A forgotten clinical entity! (2016) Clin Cases Mineral Bone Metab, 13 (1), pp. 15-18 ;\n Mateo, R.C., Apel, J., Hypercalcemia induced by advanced chronic liver disease without malignancy (2015) Endocrine Society’s 97Th Annual Meeting and Expo, , San Diego, March", "hasCitationDuplums" : false, "userChangeableUntil" : "2020-06-10T07:20:19.728+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 4, "ownerInstituteCount" : 11, "directInstituteCount" : 0, "authorCount" : 5, "contributorCount" : 0, "book" : { "otype" : "Book", "mtid" : 31237426, "link" : "/api/publication/31237426", "label" : "Metabolic Bone Diseases: A Case-Based Approach. (2019) ISBN:9783030036935; 9783030036942", "core" : false, "citation" : false, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Könyv", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "title" : "Metabolic Bone Diseases: A Case-Based Approach", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 16747622, "link" : "/api/publicationidentifier/16747622", "label" : "ISBN: 9783030036935", "source" : { "otype" : "PlainSource", "mtid" : 122, "link" : "/api/publicationsource/122", "label" : "ISBN", "type" : { "otype" : "PublicationSourceType", "mtid" : 10002, "link" : "/api/publicationsourcetype/10002", "label" : "Egyéb", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "ISBN", "nameEng" : "ISBN", "linkPattern" : "https://www.worldcat.org/search?q=isbn%3A@@@", "publiclyVisible" : true, "published" : true, "oldId" : 122, "snippet" : true }, "idValue" : "9783030036935", "realUrl" : "https://www.worldcat.org/search?q=isbn%3A9783030036935", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 16747621, "link" : "/api/publicationidentifier/16747621", "label" : "ISBN: 9783030036942", "source" : { "otype" : "PlainSource", "mtid" : 122, "link" : "/api/publicationsource/122", "label" : "ISBN", "type" : { "otype" : "PublicationSourceType", "mtid" : 10002, "link" : "/api/publicationsourcetype/10002", "label" : "Egyéb", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "ISBN", "nameEng" : "ISBN", "linkPattern" : "https://www.worldcat.org/search?q=isbn%3A@@@", "publiclyVisible" : true, "published" : true, "oldId" : 122, "snippet" : true }, "idValue" : "9783030036942", "realUrl" : "https://www.worldcat.org/search?q=isbn%3A9783030036942", "published" : false, "snippet" : true } ], "publishedAt" : [ ], "publishedYear" : 2019, "foreignLanguage" : true, "fullPublication" : false, "published" : true, "snippet" : true }, "hasQualityFactor" : false, "link" : "/api/publication/31238893", "label" : "Meah F. et al. Non-PTH-mediated hypercalcemia. (2019) Megjelent: Metabolic Bone Diseases: A Case-Based Approach pp. 27-42", "template" : "